# Effect of Intravitreal Anti-VEGF on Retinal Vessels Diameter

> **NCT01626339** · NA · UNKNOWN · sponsor: **University of Malaya** · enrollment: 30 (estimated)

## Conditions studied

- Age Related Macular Degeneration

## Interventions

- **DRUG:** Intravitreal Ranibizumab
- **DRUG:** Intravitreal bevacizumab

## Key facts

- **NCT ID:** NCT01626339
- **Lead sponsor:** University of Malaya
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-04
- **Primary completion:** 2012-06
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2012-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01626339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01626339, "Effect of Intravitreal Anti-VEGF on Retinal Vessels Diameter". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01626339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*